[What is reliable in the therapy of hematologic diseases? I. Hemoblastosis and malignant lymphoproliferative diseases].
D000970:Antineoplastic Agents / Q000627:therapeutic use; D001853:Bone Marrow / Q000187:drug effects; D005334:Fever / Q000150:complications; D006402:Hematologic Diseases / Q000188:drug therapy*; D006689:Hodgkin Disease / Q000188:drug therapy / Q000532:radiotherapy; D006801:Humans; D007239:Infections / Q000150:complications; D007938:Leukemia / Q000188:drug therapy*; D007945:Leukemia, Lymphoid / Q000188:drug therapy / Q000532:radiotherapy; D007951:Leukemia, Myeloid / Q000188:drug therapy / Q000532:radiotherapy; D008223:Lymphoma / Q000188:drug therapy*; D016403:Lymphoma, Large B-Cell, Diffuse / Q000188:drug therapy; D008228:Lymphoma, Non-Hodgkin / Q000532:radiotherapy; D010954:Plasmacytoma / Q000188:drug therapy / Q000532:radiotherapy; D011537:Pruritus / Q000150:complications; D011879:Radiotherapy Dosage; D008258:Waldenstrom Macroglobulinemia / Q000188:drug therapy
D000970:Antineoplastic Agents
Was ist gesichert in der Therapie der hämatologischen Erkrankungen? I. Hämoblastosen und maligne lymphoproliferative Erkrankungen.